DSF could modulate lipid metabolism and oxidative stress in mouse models of NAFLD (Liu et al., 2018), as well as could inactivate the NLRP3 inflammasome and reduce mitochondrial-independent reactive oxygen species (ROS) production (Deng et al., 2020). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.